SAN

100.98

+2.15%↑

EI

254.4

-4%↓

SHL.DE

48.14

-2.57%↓

ARGX

546.8

+3.72%↑

PHIA

22.74

-0.79%↓

SAN

100.98

+2.15%↑

EI

254.4

-4%↓

SHL.DE

48.14

-2.57%↓

ARGX

546.8

+3.72%↑

PHIA

22.74

-0.79%↓

SAN

100.98

+2.15%↑

EI

254.4

-4%↓

SHL.DE

48.14

-2.57%↓

ARGX

546.8

+3.72%↑

PHIA

22.74

-0.79%↓

SAN

100.98

+2.15%↑

EI

254.4

-4%↓

SHL.DE

48.14

-2.57%↓

ARGX

546.8

+3.72%↑

PHIA

22.74

-0.79%↓

SAN

100.98

+2.15%↑

EI

254.4

-4%↓

SHL.DE

48.14

-2.57%↓

ARGX

546.8

+3.72%↑

PHIA

22.74

-0.79%↓

Search

Fresenius SE & Co KGaA

Abrir

SetorSaúde

39.59 2.27

Visão Geral

Variação de preço das ações

24h

Atual

Mín

38.67

Máximo

39.72

Indicadores-chave

By Trading Economics

Rendimento

-55M

264M

Vendas

264M

5.6B

P/E

Médio do Setor

48.146

63.778

Margem de lucro

4.689

Funcionários

176,486

EBITDA

-33M

724M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+14.99% upside

Dividendos

By Dow Jones

Próximos Ganhos

7 de mai. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

1.4B

22B

Abertura anterior

37.32

Fecho anterior

39.59

Sentimento de Notícias

By Acuity

35%

65%

122 / 386 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Fresenius SE & Co KGaA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

26 de fev. de 2025, 13:37 UTC

Conversa de Mercado

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

5 de jun. de 2024, 12:18 UTC

Conversa de Mercado

Fresenius Helios Guidance Lift Should Drive Consensus Upgrades -- Market Talk

Comparação entre Pares

Variação de preço

Fresenius SE & Co KGaA Previsão

Preço-alvo

By TipRanks

14.99% parte superior

Previsão para 12 meses

Média 45.4 EUR  14.99%

Máximo 48 EUR

Mínimo 42 EUR

Com base em 12 analistas de Wall Street que oferecem metas de preço de 12 meses para Fresenius SE & Co KGaA - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

12 ratings

11

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

39.31 / 40.17Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

122 / 386 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Fresenius SE & Co KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.